does glp-1 increase heart rate receptor agonists and myocardial metabolism in atrial fibrillation Differential effects of glucagon-like peptide-1

Additional adverse effects may include injection site reactions and, rarely, pancreatitis

It does not play well with strong actives that drive exfoliation or significantly alter skin pH

What Each Peptide Is Sermorelin is a 29-amino-acid peptide that acts as a growth-hormone-releasing hormone (GHRH) analog

Semaglutide, by contrast, activates GLP-1 receptors in the pancreas and brain to reduce appetite, slow gastric emptying, and improve insulin sensitivity

People comparing phentermine versus GLP-1 approaches or phentermine versus semaglutide specifically should factor in how each option interacts with existing diabetes management